tiprankstipranks
Advertisement
Advertisement

Cresco Labs Secures Vertically Integrated Medical Cannabis License in Texas

Story Highlights
  • Cresco Labs won a vertically integrated Texas medical cannabis license, validating its regulatory strengths.
  • The Texas license advances Cresco’s state-by-state expansion, opening access to a major emerging patient market.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cresco Labs Secures Vertically Integrated Medical Cannabis License in Texas

Claim 55% Off TipRanks

Cresco Labs ( (TSE:CL) ) has shared an update.

Cresco Labs has been conditionally awarded a vertically integrated license under the Texas Compassionate Use Program, allowing it to cultivate, process and dispense medical cannabis in the state. Management framed the win as a validation of the company’s regulatory expertise and patient-first approach in medical markets.

The license gives Cresco Labs a strategic entry into Texas, the second-most populous U.S. state, aligning with its disciplined, state-by-state expansion strategy. Access to this large and potentially expanding patient base is expected to support the build-out of a scaled, long-term platform, leveraging the company’s cash generation and balance sheet to grow its medical cannabis operations and brand presence in a key emerging market.

The most recent analyst rating on (TSE:CL) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Cresco Labs stock, see the TSE:CL Stock Forecast page.

Spark’s Take on CL Stock

According to Spark, TipRanks’ AI Analyst, CL is a Neutral.

The score is held back primarily by weak financial performance (sharp revenue contraction, continued net losses, and worsening leverage despite positive cash flow). Technicals are mixed with soft momentum, while the earnings call adds modest support through margin/cash-flow progress and improved maturity profile but is tempered by near-term revenue and margin headwinds. Valuation is difficult to support due to negative earnings and no dividend yield.

To see Spark’s full report on CL stock, click here.

More about Cresco Labs

Cresco Labs Inc. is a U.S. cannabis company focused on branded medical and adult-use products and a national retail footprint. The company operates the Sunnyside chain of dispensaries and markets a portfolio of consumer packaged cannabis brands, including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, with an emphasis on regulatory stewardship and community engagement.

Average Trading Volume: 124,126

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$565.6M

Learn more about CL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1